# Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist

> **NCT00830492** · PHASE4 · COMPLETED · sponsor: **Yazd Research & Clinical Center for Infertility** · enrollment: 200 (estimated)

## Conditions studied

- Ovarian Stimulation

## Interventions

- **DRUG:** clomiphene citrate
- **PROCEDURE:** Ultrasound
- **DRUG:** GnRH antagonist
- **DRUG:** gonadotopin (HMG)
- **DRUG:** buserelin
- **DRUG:** rFSH

## Key facts

- **NCT ID:** NCT00830492
- **Lead sponsor:** Yazd Research & Clinical Center for Infertility
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2009-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00830492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00830492, "Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00830492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*